Direct Introduction of an Alkylsulfonamido Group on C-sites of Isomeric Dicarba-closo-dodecaboranes: The Influence of Stereochemistry on Inhibitory Activity against the Cancer-Associated Carbonic Anhydrase IX Isoenzyme
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
18-27648S
Grantová Agentura České Republiky
15-05677S
Grantová Agentura České Republiky
TE01020028
Technology Agency of the Czech Republic
PPLZ L200321851
Akademie Věd České Republiky
CZ.02.1.01/0.0/0.0/16_019/0000729
European Regional Development Fund
PubMed
32757220
DOI
10.1002/chem.202002809
Knihovny.cz E-zdroje
- Klíčová slova
- carbonic anhydrase, crystallography, dicarba-closo-dodecaboranes, inhibitors, sulfonamide,
- MeSH
- antigeny nádorové chemie metabolismus MeSH
- inhibitory karboanhydras * farmakologie MeSH
- izoenzymy MeSH
- karboanhydrasa I chemie metabolismus MeSH
- karboanhydrasa IX chemie metabolismus MeSH
- lidé MeSH
- nádory * MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- antigeny nádorové MeSH
- inhibitory karboanhydras * MeSH
- izoenzymy MeSH
- karboanhydrasa I MeSH
- karboanhydrasa IX MeSH
Carbonic anhydrase IX (CA IX), a tumor-associated metalloenzyme, represents a validated target for cancer therapy and diagnostics. Herein, we report the inhibition properties of isomeric families of sulfonamidopropyl-dicarba-closo-dodecaboranes group(s) prepared using a new direct five-step synthesis from the corresponding parent cages. The protocol offers a reliable solution for synthesis of singly and doubly substituted dicarba-closo-dodecaboranes with a different geometric position of carbon atoms. The closo-compounds from the ortho- and meta-series were then degraded to corresponding 11-vertex dicarba-nido-undecaborate(1-) anions. All compounds show in vitro enzymatic activity against CA IX in the low nanomolar or subnanomolar range. This is accompanied by clear isomer dependence of the inhibition constant (Ki ) and selectivity towards CA IX. Decreasing trends in Ki and selectivity index (SI ) values are observed with increasing separation of the cage carbon atoms. Interactions of compounds with the active sites of CA IX were explored with X-ray crystallography, and eight high-resolution crystal structures uncovered the structural basis of inhibition potency and selectivity.
Zobrazit více v PubMed
R. N. Grimes, Carboranes, 3rd ed., Academic Press, London, 2016, pp. 1-1041.
J. Dvořanová, M. Kugler, J. Holub, V. Šícha, V. Das, J. Nekvinda, S. El Anwar, M. Havránek, K. Pospíšilová, M. Fábry, V. Král, M. Medvedíková, S. Matějková, B. Lišková, S. Gurská, P. Džubák, J. Brynda, M. Hajdúch, B. Grüner, P. Řezáčová, Eur. J. Med. Chem. 2020, 200, 112460.
R. Frank, V. Ahrens, S. Boehnke, S. Hofmann, M. Keltert, S. Saretz, S. Pandey, M. Sarosi, A. Bartok, A. G. Beck-Sickinger, E. Hey-Hawkins, Pure Appl. Chem. 2015, 87, 163-171;
C. Selg, W. Neumann, P. Lonnecke, E. Hey-Hawkins, K. Zeitler, Chem. Eur. J. 2017, 23, 7932-7937.
M. Couto, C. Alamon, C. Sanchez, B. Davila, M. Fernandez, N. Lecot, P. Cabral, F. Teixidor, C. Vinas, H. Cerecetto, Future Med. Chem. 2019, 11, 2273-2285;
M. Sibrian-Vazquez, E. H. Hao, T. J. Jensen, M. G. H. Vincente, Bioconjugate Chem. 2006, 17, 928-934;
Z. J. Leśnikowski, J. Med. Chem. 2016, 59, 7738-7758;
Z. J. Leśnikowski, Expert. Opin. Drug Discov. 2016, 11, 569-578.
D. Gabel, Pure Appl. Chem. 2015, 87, 173-179;
F. Issa, M. Kassiou, M. Rendina, Chem. Rev. 2011, 111, 5701-5722;
J. Kahlert, C. J. D. Austin, M. Kassiou, L. M. Rendina, Aust. J. Chem. 2013, 66, 1118-1123;
R. Satapathy, B. P. Dash, J. A. Maguire, N. S. Hosmane, Collect. Czech. Chem. C 2010, 75, 995-1022;
M. Scholz, E. Hey-Hawkins, Chem. Rev. 2011, 111, 7035-7062;
P. Stockmann, M. Gozzi, R. Kuhnert, M. B. Sarosi, E. Hey-Hawkins, Chem. Soc. Rev. 2019, 48, 3497-3512;
J. F. Valliant, K. J. Guenther, A. S. King, P. Morel, P. Schaffer, O. O. Sogbein, K. A. Stephenson, Coord. Chem. Rev. 2002, 232, 173-230.
G. R. Kracke, M. R. VanGordon, Y. V. Sevryugina, P. J. Kueffer, K. Kabytaev, S. S. Jalisatgi, M. F. Hawthorne, ChemMedChem 2015, 10, 62-67.
L. N. Goswami, T. J. Olds, T. G. Monk, Q. L. Johnson, J. P. Dilger, M. A. Shanawaz, S. S. Jalisatgi, M. F. Hawthorne, G. R. Kracke, ChemMedChem 2019, 14, 1108-1114.
M. Laube, W. Neumann, M. Scholz, P. Lonnecke, B. Crews, L. J. Marnett, J. Pietzsch, T. Kniess, E. Hey-Hawkins, ChemMedChem 2013, 8, 329-335;
M. Scholz, A. L. Blobaum, L. J. Marnett, E. Hey-Hawkins, Bioorg. Med. Chem. 2012, 20, 4830-4837;
S. Stadlbauer, R. Frank, M. Scholz, S. Boehnke, V. M. Ahrens, A. G. Beck-Sickinger, E. Hey-Hawkins, Pure Appl. Chem. 2012, 84, 2289-2298.
M. B. Sárosi, W. Neumann, T. P. Lybrand, E. Hey-Hawkins, J. Chem. Inf. Model. 2017, 57, 2056-2067.
J. Brynda, P. Mader, V. Šícha, M. Fábry, K. Poncová, M. Bakardiev, B. Grüner, P. Cígler, P. Řezáčová, Angew. Chem. Int. Ed. 2013, 52, 13760-13763;
Angew. Chem. 2013, 125, 14005-14008.
G. De Simone, A. Scozzafava, C. T. Supuran, Chem. Biol. Drug Des. 2009, 74, 317-321;
I. Fidan, R. E. Salmas, M. Arslan, M. Senturk, S. Durdagi, D. Ekinci, E. Senturk, S. Cosgun, C. T. Supuran, Bioorg. Med. Chem. 2015, 23, 7353-7358;
S. C. Frost, Subcell. Biochem. 2014, 75, 9-30;
B. P. Mahon, C. L. Lomelino, J. Ladwig, G. M. Rankin, J. M. Driscoll, A. L. Salguero, M. A. Pinard, D. Vullo, C. T. Supuran, S. A. Poulsen, R. McKenna, J. Med. Chem. 2015, 58, 6630-6638;
R. McKenna, S. C. Frost, Subcell. Biochem. 2014, 75, 3-5;
J. Moeker, B. P. Mahon, L. F. Bornaghi, D. Vullo, C. T. Supuran, R. McKenna, S. A. Poulsen, J. Med. Chem. 2014, 57, 8635-8645;
R. P. Tanpure, B. Ren, T. S. Peat, L. F. Bornaghi, D. Vullo, C. T. Supuran, S. A. Poulsen, J. Med. Chem. 2015, 58, 1494-1501;
B. P. Mahon, M. A. Pinard, R. McKenna, Molecules 2015, 20, 2323-2348.
J. S. Yang, C. W. Lin, Y. H. Hsieh, M. H. Chien, C. Y. Chuang, S. F. Yang, Oncotarget 2017, 8, 83088-83099.
B. Cornelio, M. Laronze-Cochard, M. Ceruso, M. Ferraroni, G. A. Rance, F. Carta, A. N. Khlobystov, A. Fontana, C. T. Supuran, J. Sapi, J. Med. Chem. 2016, 59, 721-732;
R. McKenna, C. T. Supuran, Carbonic Anhydrase Inhibitors Drug Design, Vol. 75 (Eds.: S. C. Frost, R. McKenna), Springer, New York, 2014, pp. 291-323;
C. T. Supuran, J. Enzym. Inhib. Med. Chem. 2016, 31, 345-360;
J. Y. Winum, C. T. Supuran, J. Enzym. Inhib. Med. Chem. 2015, 30, 321-324.
R. J. Pace, J. Williams, R. L. Williams, J. Chem. Soc. 1961, 2196.
S. Janczak, A. Olejniczak, S. Balabańska, M. K. Chmielewski, M. Lupu, C. Viñas, Z. J. Lesnikowski, Chem. Eur. J. 2015, 21, 15118-15122;
V. N. Kalinin, E. G. Rys, A. A. Tyutyunov, A. Z. Starikova, A. A. Korlyukov, V. A. Ol'shevskaya, D. D. Sung, A. B. Ponomaryov, P. V. Petrovskii, E. Hey-Hawkins, Dalton Trans. 2005, 903-908.
Z. Benfodda, F. Guillen, H. Arnion, A. Dahmani, H. Blancou, Heteroat. Chem. 2009, 20, 355-361.
C. Bolli, J. Derendorf, C. Jenne, H. Scherer, C. P. Sindlinger, B. Wegener, Chem. Eur. J. 2014, 20, 13783-13792;
T. García-Mendiola, V. Bayon-Pizarro, A. Zaulet, I. Fuentes, F. Pariente, F. Teixidor, C. Vinas, E. Lorenzo, Chem. Sci. 2016, 7, 5786-5797;
W. X. Gu, B. J. McCulloch, J. H. Reibenspies, O. V. Ozerov, Chem. Commun. 2010, 46, 2820-2822;
W. X. Gu, O. V. Ozerov, Inorg. Chem. 2011, 50, 2726-2728;
R. Ramírez-Contreras, O. V. Ozerov, Dalton Trans. 2012, 41, 7842-7844;
M. Saleh, D. R. Powell, R. J. Wehmschulte, Inorg. Chem. 2016, 55, 10617-10627.
J. Plešek, S. Heřmánek, B. Štíbr, Inorg. Synth. 1983, 22, 231-234;
M. A. Fox, A. E. Goeta, A. K. Hughes, A. L. Johnson, J. Chem. Soc. Dalton Trans. 2002, 2132-2141.
M. A. Pinard, C. D. Boone, B. D. Rife, C. T. Supuran, R. McKenna, Bioorg. Med. Chem. 2013, 21, 7210-7215.
B. Grüner, J. Brynda, V. Das, V. Šícha, J. Stěpánková, J. Nekvinda, J. Holub, K. Pospíšilová, M. Fábry, P. Pachl, V. Král, M. Kugler, V. Mašek, M. Medvedíková, S. Matějková, A. Nová, B. Lišková, S. Gurská, P. Džubák, M. Hajdůch, P. Řezáčová, J. Med. Chem. 2019, 62, 9560-9575.
R. G. Khalifah, J. Biol. Chem. 1971, 246, 2561.
U. Mueller, R. Förster, M. Hellmig, F. U. Huschmann, A. Kastner, P. Malecki, S. Pühringer, M. Röwer, K. Sparta, M. Steffien, M. Ühlein, P. Wilk, M. S. Weiss, Eur. Phys. J. Plus 2015, 130, 141.
W. Kabsch, Acta Crystallogr. Sect. D 2010, 66, 125-132;
W. Kabsch, Acta Crystallogr. Sect. D 2010, 66, 133-144.
R. Ahlrichs, M. Bär, M. Häser, H. Horn, C. Kölmel, Chem. Phys. Lett. 1989, 162, 165-169.
P. Jurečka, J. Černý, P. Hobza, D. R. Salahub, J. Comput. Chem. 2007, 28, 555-569.
A. A. Vagin, G. N. Murshudov, B. V. Strokopytov, J. Appl. Crystallogr. 1998, 31, 98-102.
P. Emsley, K. Cowtan, Acta Crystallogr. Sect. D 2004, 60, 2126-2132.
G. N. Murshudov, A. A. Vagin, E. J. Dodson, Acta Crystallogr. Sect. D 1997, 53, 240-255.
V. B. Chen, W. B. Arendall, 3rd, J. J. Headd, D. A. Keedy, R. M. Immormino, G. J. Kapral, L. W. Murray, J. S. Richardson, D. C. Richardson, Acta Crystallogr. Sect. D 2010, 66, 12-21.
Schrodinger, LLC in The PyMOL Molecular Graphics System, Version 1.8, Vol. 2015.
M. D. Winn, C. C. Ballard, K. D. Cowtan, E. J. Dodson, P. Emsley, P. R. Evans, R. M. Keegan, E. B. Krissinel, A. G. W. Leslie, A. McCoy, S. J. McNicholas, G. N. Murshudov, N. S. Pannu, E. A. Potterton, H. R. Powell, R. J. Read, A. Vagin, K. S. Wilson, Acta Crystallogr. Sect. D 2011, 67, 235-242.
E. Krissinel, K. Henrick, J. Mol. Biol. 2007, 372, 774-797.